Results for Graft vs Host Disease

Rss Feed: Click here

EGCG ameliorates lethal graft versus host disease and reduces related target organ damage.

Article Published Date : Dec 31, 2016

Study Type : Animal Study

Additional Links

Substances : EGCG (Epigallocatechin gallate) : CK(1091) : AC(605)

Diseases : Graft vs Host Disease : CK(2) : AC(1)

Pharmacological Actions : Antioxidants : CK(21528) : AC(8856), Immunomodulatory : CK(4048) : AC(1475)

Additional Keywords : Antioxidants : CK(303) : AC(126), EGCG (Epigallocatechin gallate), Graft vs Host Disease, Hematopoietic Stem Cells : CK(19) : AC(7), Immunomodulatory, Risk Reduction : CK(15144) : AC(1708)

Click here to view the entire abstract

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.